Pomalidomide

Pomalyst

Strengths & Sizes

Pomalidomide
Pomalidomide

Note: product and packaging images are not actual size

  • NDC#31722-770-21
  • UPC Code331722770217
  • ImprintH / P1
Download Label
Download HDA Sheet
Pomalidomide
Pomalidomide

Note: product and packaging images are not actual size

  • NDC#31722-771-21
  • UPC Code331722771214
  • ImprintH / P2
Download Label
Download HDA Sheet
Pomalidomide
Pomalidomide

Note: product and packaging images are not actual size

  • NDC#31722-772-21
  • UPC Code331722772211
  • ImprintH / P3
Download Label
Download HDA Sheet
Pomalidomide
Pomalidomide

Note: product and packaging images are not actual size

  • NDC#31722-773-21
  • UPC Code331722773218
  • ImprintH / P4
Download Label
Download HDA Sheet

Indications

Pomalidomide capsules, in combination with dexamethasone, is indicated for adult patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Go Back To The Product Listing Page